Genprex Inc GNPX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:26 PM EDT
2.38quote price arrow up+0.06 (+2.59%)
Volume
232
Close
2.32quote price arrow down-0.11 (-4.53%)
Volume
20,132
52 week range
2.09 - 42.40
Loading...
  • Open2.44
  • Day High2.55
  • Day Low2.30
  • Prev Close2.43
  • 52 Week High42.40
  • 52 Week High Date06/02/23
  • 52 Week Low2.09
  • 52 Week Low Date04/26/24

Key Stats

  • Market Cap4.869M
  • Shares Out2.10M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-0.61
  • YTD % Change-74.78

KEY STATS

  • Open2.44
  • Day High2.55
  • Day Low2.30
  • Prev Close2.43
  • 52 Week High42.40
  • 52 Week High Date06/02/23
  • 52 Week Low2.09
  • 52 Week Low Date04/26/24
  • Market Cap4.869M
  • Shares Out2.10M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-0.61
  • YTD % Change-74.78

RATIOS/PROFITABILITY

  • EPS (TTM)-22.93
  • P/E (TTM)-0.10
  • Fwd P/E (NTM)-0.35
  • EBITDA (TTM)-31.065M
  • ROE (TTM)-207.88%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/22/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Genprex Inc

 

Content From Our Affiliates

Profile

MORE
Genprex, Inc. is a clinical-stage gene therapy company. The Company is focused on the development of gene-based therapies for patients with unmet medical needs. The Company's lead oncology drug candidate, REQORSA Immunogen therapy drug (quaratusugene ozeplasmid), is being developed to treat non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). The active agent in REQORSA is a plasmid that expresses a tumor suppressor gene named TUSC2. REQORSA consists of the...
J. Rodney Varner
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Ryan Confer
Chief Financial Officer
Hemant Kumar Ph.D.
Chief Manufacturing and Technology Officer
Catherine Vaczy Esq., J.D.
Executive Vice President, General Counsel, Chief Strategy Officer
Address
1601 Trinity Street
Bldg. B, Suite 3.322
Austin, TX
78712
United States

Top Peers

SYMBOLLASTCHG%CHG
KPRX
Kiora Pharmaceuticals Inc
0.4862+0.0009+0.1855%
NNVC
NanoViricides Inc
1.89+0.06+3.28%
COEP
Coeptis Therapeutics Holdings Inc
0.3802+0.0142+3.8798%
MNPR
Monopar Therapeutics Inc
0.6722-0.0389-5.4704%
IMNN
Imunon Inc
1.38-0.13-8.61%